Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse reactions attributed to sumatriptan. A postmarketing study in general practice

J P Ottervanger1, T B van Witsen, H A Valkenburg

  • 1Netherlands Centre for Monitoring of Adverse Reactions to Drugs, Rijswijk.

European Journal of Clinical Pharmacology
|January 1, 1994
PubMed
Summary

This study investigated sumatriptan

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users?

European geriatric medicine·2023
Same author

Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.

PloS one·2022
Same author

Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults.

PloS one·2022
Same author

Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-up.

Cancer epidemiology·2022
Same author

A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons.

Drugs & aging·2021
Same author

Prevalence of and risk factors for extended-spectrum beta-lactamase genes carriership in a population-based cohort of middle-aged and elderly.

International journal of antimicrobial agents·2021

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Cardiology

Background:

  • Sumatriptan is an antimigraine medication.
  • Reports of cardiac adverse reactions to sumatriptan have emerged.
  • Postmarketing surveillance is crucial for assessing drug safety.

Purpose of the Study:

  • To determine the frequency and characteristics of adverse reactions to sumatriptan.
  • To evaluate the safety profile of sumatriptan in a real-world setting.
  • To assess the causal relationship between sumatriptan use and reported adverse events.

Main Methods:

  • A postmarketing cohort study was conducted in The Netherlands.
  • Data was collected from 1727 patients who received sumatriptan.
  • Questionnaires were sent to patients via general practitioners to gather information on drug use and adverse reactions.

Related Experiment Videos

Main Results:

  • The most frequent adverse reactions were paresthesia (139 patients) and dizziness (96 patients).
  • Chest pain was reported by 7.9% of patients, with a probable causal link to sumatriptan, particularly in females.
  • Dyspnea was reported by 2.2% of patients and was associated with obstructive lung disease.

Conclusions:

  • Sumatriptan use is associated with adverse reactions including chest pain and dyspnea.
  • The frequency of chest pain was higher in females.
  • Obstructive lung disease is a risk factor for sumatriptan-attributed dyspnea.